List of SARS-CoV-2 Variants & Classifications

Biomeme continuously monitors and analyzes sequences of emerging variants of concern and updates...

The finalists have been announced and Biomeme is moving forward to the next round of XPRIZE Rapid COVID Testing, a $6 million dollar 6-month...

When you walk into Biomeme HQ in Philadelphia, you’ll find a bustling office overflowing with our staff, incoming and outgoing packages, and an...

Launched on July 28, 2020, XPRIZE Rapid Covid Testing is a $5 million, 6-month competition that aims to increase Covid-19 testing capabilities...

We all want to make the world a better place, right?

Whether you’re a doctor, public servant, or construction worker, we all play a part in making...

We are pleased to announce that the U.S. Food and Drug Administration (FDA) granted Biomeme’s SARS-CoV-2 Real-Time RT-PCR Test Emergency Use...

“Ahhhh-CHOO!”

Cut to me frantically searching “COVID-19 symptoms” on Google for what must be the millionth time this year.

“Could I have...

With the results of the AMR Challenge quickly approaching, we wanted to take a moment to reflect on our amazing team’s development activities over...

We are proud to announce that Biomeme’s portable test solution to detect SARS-CoV-2 was approved for in vitro diagnostic use by Health Canada on...

Ania Tomaszewicz Brown, Denise McAloose, Paul P. Calle, Angelika Auer, Annika Posautz, Sally Slavinski, Robin Brennan, Chris Walzer, and Tracie A....